about
Associations between purine metabolites and clinical symptoms in schizophreniaGlutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trialHomeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophreniaOxidative stress in schizophreniaCellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegenerationAbnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autismRole of melatonin in schizophreniaInflammation and schizophreniaSchizophrenia: One Coat of Many ColorsIn vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophreniaNutritional interventions for the adjunctive treatment of schizophrenia: a brief reviewGlutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patientsNegative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS studyTargeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionHow Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.Inhibitory interneurons, oxidative stress, and schizophrenia.Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia.N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Meta-analysis of oxidative stress in schizophrenia.Erythrocyte glutathione levels as long-term predictor of transition to psychosisElectrophysiological intermediate biomarkers for oxidative stress in schizophreniaAntioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine TreatmentReduced antioxidant defense in early onset first-episode psychosis: a case-control study.Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia.Impaired metabolic reactivity to oxidative stress in early psychosis patientsOxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.Food-derived opioid peptides inhibit cysteine uptake with redox and epigenetic consequences.Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?Pro198Leu polymorphism in the oxidative stress gene, glutathione peroxidase-1, is associated with a gender-specific risk for panic disorder.Oxidative stress in schizophrenia: an integrated approach.Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility geneGenetic association studies of antioxidant pathway genes and schizophrenia.Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophreniaNiacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
P2860
Q21560779-0C9C2CBD-3D48-4A65-8B05-A5F627D5DEA9Q21560890-8F326410-CFD6-48E6-9508-F803FF8E1646Q21562668-21AA1661-D9F9-4C7B-A44A-C05987763C80Q24595660-23727A91-882E-4D1F-8373-36B8E496CC8DQ24654460-40675509-6D8B-4A12-B667-F493787B228EQ24656561-6752871B-7EE6-4183-AA8C-009300739818Q26825564-AF0EDD8D-D0FC-4F65-A4AE-4A0001D28348Q27002489-951B01F1-B73B-4547-A6DB-4796326475E9Q27500448-FDC1A329-FBFB-4F2E-9560-05482C73B49EQ28083121-3C6BA23A-D6BC-4713-934A-A06130763D51Q28248117-D05A2C7F-57C9-4C22-AEDD-1C5C735C3177Q28257370-DF799D25-1D91-4EAF-A3B4-B0769F9D756BQ28472479-19E63B89-BEDE-472E-8531-F8B7901C7559Q30380519-705F6BC2-9219-496C-8AB4-6832BD1A5DCAQ30386608-8F2F601B-37E9-4E42-A218-4998B9C31679Q30439924-403F194F-D37E-4E9D-9E98-19A924C796A8Q30455112-93FA4191-84FB-4D3B-B0EB-FC57DC874FE0Q30457809-758AAB0C-5E1A-4F28-9357-49F56E670DF8Q30474021-CA7B90D2-12DE-4831-BCA9-B7DE56B2C3C2Q30490910-9A42BA4A-5FC5-4EF3-A0E1-A344E2A317C5Q33350202-1250790E-4159-4C4D-835D-4D364D02E7D8Q33601360-5FE04730-8CA3-4D9B-BC80-2CA4D90D26B3Q33635566-A73BAA90-0120-4D57-AE64-9A051D433F5EQ33647885-313DB165-0F4E-47A4-B2F5-4A849F62888DQ33766147-7492B9AF-3AA1-4F8F-9D82-5684EE8088A9Q33820188-48665924-08A6-4FBA-AA2E-43F2EB1D543EQ33979025-7B451B01-948A-42B8-A225-C9C51D14FAE3Q33988027-BBBCABF3-2CF5-483C-8188-4CB13BA65E15Q34048645-5AD063C5-93A6-4F52-9FAD-153B0DDF5B18Q34084286-E7D8BD14-A870-4C59-9B45-E34553032478Q34150427-B07FC6C5-2783-4040-8CBA-EFCC1D056C76Q34192207-0A84F8FB-1A3F-4655-BBA4-84420A73E8C9Q34351848-23CEDAB7-B68A-46C2-924B-2D0D87EFE9A7Q34428194-88FAE925-E679-4AFD-B7A4-38B77C417485Q34462000-E02449C3-40EF-445B-A933-2909295AC075Q34494844-E33395E0-D418-485F-A010-C167B9C043DDQ35015897-1C645F8B-B9C8-42DA-8BE4-BB2ACD9E2158Q35173614-C15D9E0B-CEFD-4AB0-93BA-8341F5B107E5Q35872055-5A0B4A7E-26FD-4EB1-A675-BCC5C566A3CDQ35928509-62E05355-494F-4EFF-8661-A4BD4036C389
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Altered glutathione redox state in schizophrenia.
@en
Altered glutathione redox state in schizophrenia.
@nl
type
label
Altered glutathione redox state in schizophrenia.
@en
Altered glutathione redox state in schizophrenia.
@nl
prefLabel
Altered glutathione redox state in schizophrenia.
@en
Altered glutathione redox state in schizophrenia.
@nl
P2093
P356
P1433
P1476
Altered glutathione redox state in schizophrenia.
@en
P2093
Jeffrey K Yao
Ravinder Reddy
Sherry Leonard
P356
10.1155/2006/248387
P577
2006-01-01T00:00:00Z